Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Bipolar Disorder

Bipolar Disorder

Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.

Mania and Antimanic Drugs: Overview

Mania and Antimanic Drugs: Overview

Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...

Depression: Overview

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...

Diagnostic and Statistical Manual of Mental Disorders (DSM)

Diagnostic and Statistical Manual of Mental Disorders (DSM)

The Diagnostic and Statistical Manual of Mental Disorders (DSM) serves as the primary classification system for mental health disorders, providing standardized diagnostic criteria for clinicians and researchers. First published by the American Psychiatric Association (APA) in 1952, the DSM has undergone several revisions to reflect evolving psychiatric understanding. The fifth edition, DSM-5, released in 2013, introduced key updates that expanded diagnostic categories and modified diagnostic...

Borderline Personality Disorder

Borderline Personality Disorder

Borderline Personality Disorder is a complex and multifaceted mental health condition characterized by pervasive instability in interpersonal relationships, self-image, emotions, and impulse control. This instability manifests in extreme emotional reactions, fear of abandonment, and self-destructive behaviors. The disorder significantly impacts daily functioning, often leading to distress in both personal and professional domains.
Genetic and Environmental Contributions
Borderline Personality...

Psychosis and Antipsychotic Drugs: Overview

Psychosis and Antipsychotic Drugs: Overview

The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Thyroid hormone augmentation for bipolar disorder: a neurobiological and clinical narrative review.

International journal of bipolar disorders·2026

Same author

Improved leaf area index estimation in Jujube trees by fusing spatial-temporal features from UAV RGB time-series with a deep learning framework.

Frontiers in plant science·2026

Same author

Electroconvulsive Therapy for the Neuropsychiatric Manifestations of Amyostatic-Akinetic Encephalitis Lethargica: A Case Report.

The journal of ECT·2026

Same author

Animal models that mirror bipolar disorder's pathophysiologic complexities: focused review of common models.

Expert opinion on drug discovery·2026

Same author

Mood Stabilizers Are the First Line of Treatment for Bipolar Disorder.

Southern medical journal·2026

Same author

Challenges with clinical trial participants in studies with classical psychedelics: A position statement from the National Network of Depression Centers' task group on psychedelics and related compounds.

Journal of psychopharmacology (Oxford, England)·2026

Same journal

CV risk: if you aren't testing ACR, you aren't seeing the full picture.

Postgraduate medicine·2026

Same journal

Anti-TNF-induced vasculitis: analysis of data from the French national pharmacovigilance database.

Postgraduate medicine·2026

Same journal

Relationship of serum nesfatin-1 levels with body mass index and c-reactive protein in patients presenting to the emergency department with epileptic seizures.

Postgraduate medicine·2026

Same journal

Clinical pharmacokinetics of colistimethate sodium and formed colistin in patients with renal impairment or on dialysis modalities: a systematic review and implications for precision dosing.

Postgraduate medicine·2026

Same journal

The role of type D personality in pregnancy symptom severity, functional limitations, and maternal ambivalence.

Postgraduate medicine·2026

Same journal

Operational and demographic predictors of leaving without being seen in a high-volume tertiary emergency department: a five-year case-control study.

Postgraduate medicine·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 10, 2026

Developing a Rat Model for Bipolar Disorder

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

Bipolar disorder: an update.

Rif S El-Mallakh¹, Ahmed Z Elmaadawi, Muruga Loganathan

¹Mood Disorders Research Program, Department of Psychiatry and Behavioral Sciences, University of Louisville School of Medicine, Louisville, KY 40202, USA. rselma01@louisville.edu

Postgraduate Medicine

|August 3, 2010

Summary

This summary is machine-generated.

Newer treatments show promise for bipolar disorder mania and depression, but long-term prognosis remains unchanged. Combining medications may improve relapse prevention in bipolar disorder management.

Related Experiment Videos

Last Updated: Jun 10, 2026

Developing a Rat Model for Bipolar Disorder

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

Area of Science:

Psychiatry
Pharmacology
Clinical Medicine

Background:

Bipolar disorder treatment has seen increased clinical trials and new therapeutic options.
Second-generation antipsychotics are effective for mania, as monotherapy or adjuncts.
Antidepressants offer no additional benefit for bipolar depression and risk destabilization.

Purpose of the Study:

To review recent advances in bipolar disorder pharmacotherapy.
To evaluate the efficacy of various treatments for mania, depression, and maintenance phases.
To discuss the impact of new treatments on the overall prognosis of bipolar disorder.

Main Methods:

Review of randomized, placebo-controlled studies.
Analysis of clinical trial data on second-generation antipsychotics, antidepressants, and newer non-antidepressant agents.
Evaluation of treatment strategies for acute and maintenance phases of bipolar disorder.

Main Results:

Second-generation antipsychotics demonstrate efficacy in treating mania.
Antidepressants show no benefit for bipolar depression and may increase mood instability.
Newer agents like quetiapine, lamotrigine, modafinil, and pramipexole are effective for acute and maintenance depression.
Combination therapy appears superior to monotherapy for relapse prevention in bipolar disorder.

Conclusions:

Pharmacotherapy for bipolar disorder has advanced, particularly for mania and depression.
Maintenance treatment and the overall prognosis of bipolar disorder require further investigation.
Despite treatment advances, the long-term prognosis for bipolar disorder has not significantly improved.